RxDoctor Payments Data

Robert Quick, MD

Family Medicine · Toccoa, GANPI 1255868196

Payments from drug & device makers

$774in general payments, 2019–2025

Across 44 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$168
  • AbbVie$126
  • Amgen$87
  • Novo Nordisk$69
  • AstraZeneca$45
  • Lilly USA, LLC$35
  • plus $245 from 12 others

What the payments were for

  • Food & beverage$774100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$774 in reported general payments places this provider in the 55th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$35,644
Medicare patients
83
Services billed
321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol80$65,020
JardianceEmpagliflozin54$56,564
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$39,758
EliquisApixaban32$39,520
OzempicSemaglutide32$35,148
XareltoRivaroxaban35$24,383
MounjaroTirzepatide15$21,827
JanuviaSitagliptin Phosphate20$15,636
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$12,639
MyrbetriqMirabegron14$10,255
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$9,468
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$6,542
SymbicortBudesonide/Formoterol Fumarate18$4,181
EntrestoSacubitril/Valsartan11$3,428
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$3,323

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$45$81,840119 claims
Boehringer IngelheimJardiance$14$56,56454 claims
PfizerEliquis, Premarin$168$41,90245 claims
Novo NordiskOzempic$69$35,14832 claims
Johnson & JohnsonXarelto$29$24,38335 claims
Lilly USA, LLCMounjaro$35$21,82715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Toccoa

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →